SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-17-004419
Filing Date
2017-07-12
Accepted
2017-07-12 16:15:28
Documents
4
Period of Report
2017-07-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 p7111728k.htm 8-K 26500
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 51655
3 EXHIBIT 99.1 ex99_1.htm EX-99.1 6312
4 kbiologo.jpg GRAPHIC 17655
  Complete submission text file 0001214659-17-004419.txt   110175
Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878
Business Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 17961911
SIC: 2834 Pharmaceutical Preparations